Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Apold

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
European Journal of Human Genetics : EJHG|January 1, 1996
Relative frequency, heterogeneity and geographic clustering of PKU mutations in NorwayH G Eiken, P M Knappskog, H Boman, et al.
Human Mutation|January 1, 1995
Novel missense mutation in the phenylalanine hydroxylase gene leading to complete loss of enzymatic activityI Dianzani, P M Knappskog, L de Sanctis, et al.
Familial Cancer|October 24, 2003
Prediction of the outcome of genetic testing in HNPCC kindreds using the revised Amsterdam criteria and immunohistochemistryA T Stormorken, W Müller, B Lemkemeyer, et al.
Human Genetics|February 1, 1996
Mutations in the iduronate-2-sulfatase gene in five Norwegians with Hunter syndromeT C Olsen, H G Eiken, P M Knappskog, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2001
Genetic epidemiology of BRCA1 mutations in NorwayP Møller, K Heimdal, J Apold, et al.
The Biochemical Journal|March 1, 1995
Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Isolation and characterization of the wild-type enzymeA Martinez, P M Knappskog, S Olafsdottir, et al.
Human Genetics|September 1, 1993
The phenylketonuria G272X haplotype 7 mutation in European populationsJ Apold, H G Eiken, E Svensson, et al.
Disease Markers|December 14, 1999
Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative GroupP Møller, M M Reis, G Evans, et al.
Journal of Medical Genetics|April 17, 2008
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancersD G Evans, K N Gaarenstroom, D Stirling, et al.
Disease Markers|December 14, 1999
Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast CancerP Møller, G Evans, N Haites, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
European Journal of Human Genetics : EJHG|January 1, 1996
Relative frequency, heterogeneity and geographic clustering of PKU mutations in NorwayH G Eiken, P M Knappskog, H Boman, et al.
Human Mutation|January 1, 1995
Novel missense mutation in the phenylalanine hydroxylase gene leading to complete loss of enzymatic activityI Dianzani, P M Knappskog, L de Sanctis, et al.
Familial Cancer|October 24, 2003
Prediction of the outcome of genetic testing in HNPCC kindreds using the revised Amsterdam criteria and immunohistochemistryA T Stormorken, W Müller, B Lemkemeyer, et al.
Human Genetics|February 1, 1996
Mutations in the iduronate-2-sulfatase gene in five Norwegians with Hunter syndromeT C Olsen, H G Eiken, P M Knappskog, et al.
European Journal of Cancer (Oxford, England : 1990)|November 27, 2001
Genetic epidemiology of BRCA1 mutations in NorwayP Møller, K Heimdal, J Apold, et al.
The Biochemical Journal|March 1, 1995
Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Isolation and characterization of the wild-type enzymeA Martinez, P M Knappskog, S Olafsdottir, et al.
Human Genetics|September 1, 1993
The phenylketonuria G272X haplotype 7 mutation in European populationsJ Apold, H G Eiken, E Svensson, et al.
Disease Markers|December 14, 1999
Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative GroupP Møller, M M Reis, G Evans, et al.
Journal of Medical Genetics|April 17, 2008
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancersD G Evans, K N Gaarenstroom, D Stirling, et al.
Disease Markers|December 14, 1999
Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast CancerP Møller, G Evans, N Haites, et al.
Pageof 7